Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients

Diabetologia

Volumn 48, Issue 4, 2005, Pages 741-747

  Lattuada, G ^a   Costantino, F ^a   Caumo, A ^a   Scifo, P ^a   Ragogna, F ^a   De Cobelli, F ^a   Del Maschio, A ^a,b   Luzi, L ^a,c   Perseghin, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Insulin resistance; Intramyocellular lipid content; Lipid oxidation; Offspring of type 2 diabetic parents

Indexed keywords

ADULT; ARTICLE; CALORIMETRY; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; LIPID COMPOSITION; LIPID OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ADULT; ADULT CHILDREN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; MUSCLE FIBERS; OXIDATION-REDUCTION; PARENTS;

EID: 17844368653     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1686-6     Document Type: Article

References (33)

1. 1H NMR spectroscopy study. Diabetologia 42:113-116
2. Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119
3. 13C NMR spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
4. Coldberg SR, Simoneau JA, Thaete FL, Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853
5. Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol 277:E1130-E1141
6. Blaak EE, Wagenmakers AJM, Glatz JFC et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146-E154
7. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ (2001) Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab 86:1638-1644
8. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548-2554
9. Luzi L, Perseghin G, Tambussi G et al (2003) Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV infected patients with lipodystrophy. Am J Physiol Endocrinol Metab 284:E274-E280
10. Perseghin G, Scifo P, Danna M et al (2002) Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab 283:E556-E564
11. Goodpaster BH, Katsiaras A, Kelley DE (2003) Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52:2191-2197
12. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ (2003) Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 26:1706-1713
13. Baecke JAH, Burema J, Frijters JER (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942
14. Perseghin G, Scifo P, Pagliato E et al (2001) Gender factors affect fatty acid-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86:3188-3196
15. Perseghin G, Lattuada G, Danna M et al (2003) Insulin resistance, intramyocellular lipid content and plasma adiponectin concentrations in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285:E1174-E1181
16. Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-431
17. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86
18. Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212-1216
19. Perseghin G, Comola M, Scifo P et al (2004) Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. Am J Clin Nutr 80:357-364
20. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Int Med 113:909-915
21. Perseghin G, Ghosh S, Gerow K, Shulman GI (1997) Metabolic defects in lean, non-diabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009
22. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Unpaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671
23. He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-823
24. Gaster M, Rustan AC, Aas V, Beck-Nielsen H (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin. Evidence from cultured myotubes. Diabetes 53:542-548
25. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-2950
26. Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142
27. Schrauwen P, Hesselink MKC (2004) Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412-1417
28. Ek J, Andersen G, Urhammer SA et al (2001) Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44:2220-2226
29. Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ (2003) A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 52:1864-1871
30. Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273
31. Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Nat Acad Sci U S A 100:8466-8471
32. Thamer C, Machann J, Bachmann O et al (2003) Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88:1785-1791
33. Gan SK, Kriketos AD, Poynten AM et al (2003) Insulin action, regional fat, and myocite lipid: altered relationships with increased adiposity. Obes Res 11:1295-1305